Clark Wealth Partners
BIIB icon

Clark Wealth Partners’s Biogen BIIB Stock Holding History

Clark Wealth Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.16K Buy
14
+7
+100% +$1.48K ﹤0.01% 515
2026
Q2 		$1.51K Hold
7
– – ﹤0.01% 447
2026
Q1 		$1.28K Hold
7
– – ﹤0.01% 495
2025
Q4 		$1.23K Hold
7
– – ﹤0.01% 472
2025
Q3 		$1.23K Hold
7
– – ﹤0.01% 472
2025
Q2 		$879 Buy
+7
New +$872 ﹤0.01% 449

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Clark Wealth Partners's BIIB Position: Q3 2026 in Review

Clark Wealth Partners increased its Biogen (BIIB) stake by 100% in Q3 2026, buying an estimated $1.48K and bringing the position to 14 shares worth $3.16K. The position accounts for ﹤0.01% of the portfolio, ranked #515.

Clark Wealth Partners first reported a position in BIIB in Q2 2025 and has held it in 6 quarters since. 881 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Clark Wealth Partners held 14 shares of Biogen worth $3.16K as of Q3 2026.
  • Clark Wealth Partners bought 7 Biogen shares in Q3 2026, an estimated $1.48K.
  • Biogen made up ﹤0.01% of Clark Wealth Partners's portfolio in Q3 2026, its #515 holding.
  • Clark Wealth Partners first reported a position in Biogen in Q2 2025 and has held it in 6 quarters since.
  • 881 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Clark Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.